0001193125-22-084033 Sample Contracts

AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF LANDOS BIOPHARMA, INC. FORM OF PREFERRED STOCK WARRANT AGREEMENT

Preferred Stock Warrant Agreement • March 24th, 2022 • Landos Biopharma, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Preferred Stock Warrant Agreement
• Filed
  March 24th, 2022
• Company
  Landos Biopharma, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

THIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between LANDOS BIOPHARMA, INC., a Delaware corporation (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).

AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [__________] LANDOS BIOPHARMA, INC. FORM OF DEBT SECURITIES WARRANT AGREEMENT

Warrant Agreement • March 24th, 2022 • Landos Biopharma, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Warrant Agreement
• Filed
  March 24th, 2022
• Company
  Landos Biopharma, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

THIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of [•], between LANDOS BIOPHARMA, INC., a Delaware corporation (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).

AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF __________ LANDOS BIOPHARMA, INC. FORM OF COMMON STOCK WARRANT AGREEMENT

Warrant Agreement • March 24th, 2022 • Landos Biopharma, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Warrant Agreement
• Filed
  March 24th, 2022
• Company
  Landos Biopharma, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

THIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between LANDOS BIOPHARMA, INC., a Delaware corporation (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).